Expression of concern

Evaluation of the Safety and Efficacy of Sildenafil Citrate for Erectile Dysfunction in Men With Multiple Sclerosis: A Double-Blind, Placebo Controlled, Randomized Study

Paper Information

Record ID:
44913
Publication Date:
January 01, 2009
Retraction Date:
January 10, 2023 (2.9 years years ago)
Subject:
Broad Categories:
Medicine
Article Type:
Publisher:
Elsevier
Open Access:
No
PubMed ID:
Retraction PubMed ID:

Expression of concern Details

Nature of Retraction:

Expression of concern

Citations (64)

64
Total Citations
5
Post-Retraction
(7.8%)
59
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
2 Within 1 year
0 After 2+ years
613 Days since retraction (latest)
Specific conditions
Clare J. Fowler, Clare J. Fowler, Clare J. Fowler
Cambridge University Press eBooks
Published: Nov 2010
2 citations
4450 days before retraction
SEX DIFFERENCES IN MULTIPLE SCLEROSIS
Elizabeth Crabtree‐Hartman
CONTINUUM Lifelong Learning in Neurology
Published: Oct 2010
8 citations
4484 days before retraction
Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study
Mohammad Reza Safarinejad, Arsia Taghva, Babak Shekarchi et al. (4 authors)
International Journal of Impotence Research
Published: Sep 2010
28 citations
4514 days before retraction
Efficacy and Safety of Tadalafil for Erectile Dysfunction in Patients with Multiple Sclerosis
Hongliang Zhang, Wei Pan, Jiang Wu
The Journal of Sexual Medicine
Published: Jun 2010
4 citations
4582 days before retraction
Nocebo effects in multiple sclerosis trials: a meta-analysis
Dimitrios Papadopoulos, DD Mitsikostas
Multiple Sclerosis Journal
Published: Jun 2010
69 citations
4597 days before retraction
Efficacy and Safety of Tadalafil for Erectile Dysfunction in Patients with Multiple Sclerosis
Giuseppe Lombardi, Angelo Macchiarella, Giulio Del Popolo
The Journal of Sexual Medicine
Published: Apr 2010
43 citations
4667 days before retraction
Pharmacotherapy for Erectile Dysfunction
Ian Eardley, Craig F. Donatucci, Jackie D. Corbin et al. (8 authors)
The Journal of Sexual Medicine
Published: Jan 2010
240 citations
4757 days before retraction
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem, Vincenza Snow, Thomas D. Denberg et al. (7 authors)
Annals of Internal Medicine
Published: Nov 2009
85 citations
4816 days before retraction
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Alexander Tsertsvadze, Howard A Fink, Fatemeh Yazdi et al. (13 authors)
Annals of Internal Medicine
Published: Nov 2009
283 citations
4816 days before retraction
Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil
Farid Dadkhah, Mohammad Reza Safarinejad, M. A. Asgari et al. (6 authors)
International Journal of Impotence Research
Published: Oct 2009
55 citations
4821 days before retraction
Current awareness: Pharmacoepidemiology and drug safety
Unknown Authors
Pharmacoepidemiology and Drug Safety
Published: Jun 2009
4971 days before retraction
Efficacy and Safety of Omega-3 for Treatment of Early-Stage Peyronie’s Disease: A Prospective, Randomized, Double-Blind Placebo-Controlled Study
Mohammad Reza Safarinejad
The Journal of Sexual Medicine Open Access
Published: Apr 2009
43 citations
5010 days before retraction
Sexual dysfunction in multiple sclerosis
Thomas M. Kessler, Clare J. Fowler, Jalesh N. Panicker
Expert Review of Neurotherapeutics
Published: Mar 2009
129 citations
5063 days before retraction
Quick Stats
Total Citations: 64
Years Since Retraction: 2.9 years
Open Access: No
Last Checked: Jul 24, 2025